Fenoterol hydrobromide/Ipratropium bromide

氢溴酸非诺特罗/异丙托溴铵

Report date: 2026/03/23 20:03:44

Base Information

Drug NameFenoterol hydrobromide/Ipratropium bromide
Drug Alias NameIpratropium bromide/Fenoterol Hydrobromide异丙托溴铵/氢溴酸非诺特罗Berodual
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonistsMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptorBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsPulmonary Disease, Chronic Obstructive
Approved Indications in ChinaN/A
Original Approved Country/TerritoryNetherlands
Original Approved Date1992/03/12
Country/TerritoryNetherlands
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsAsthma

Other Information

ATC CodeR03AL01
Related LinksN/A